Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-TICA Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes. Evaluation of Antiplatelet Therapy After 12 Months in Patients Undergoing PCI and Treated With Ticagrelor During the Acute Phase of an ACS.

NCT02265068 is registered in ClinicalTrials.gov with IHF GmbH - Institut für Herzinfarktforschung as lead sponsor.

NCT NCT02265068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02265068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-TICA Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes. Evaluation of Antiplatelet Therapy After 12 Months in Patients Undergoing PCI and Treated With Ticagrelor During the Acute Phase of an ACS.
Lead sponsor
IHF GmbH - Institut für Herzinfarktforschung
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2016
Enrollment
700 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs)